Novacta Biosystems Overview

  • Founded
  • 2000
Founded
  • Status
  • Out of Business
  • Employees
  • 51
Employees
  • Latest Deal Type
  • Liquidation

Novacta Biosystems General Information

Description

Provider of a clinical stage bio-pharmaceutical services intended to treat bacterial infections. The company's clinical stage bio-pharmaceutical services include discovery, development and commercialization of novel class small peptide molecules called lantibiotics for the treatment of bacterial infections, especially those caused by drug resistant bacteria and for the treatment of Clostridium difficile infection, providing users with anti-infectives and an infectious disease therapeutic pipeline.

Contact Information

Ownership Status
Out of Business
Financing Status
Formerly VC-backed
Primary Industry
Drug Discovery
Other Industries
Pharmaceuticals
Biotechnology
Primary Office
  • BioPark Hertfordshire
  • Broadwater Road, Welwyn Garden City
  • Hertfordshire AL7 3AX
  • England, United Kingdom
+44 01707 000000
Want detailed data on 3M+ companies?

What you see here scratches the surface

Request a free trial
Want to dig into this profile?

We’ll help you find what you need

Learn more

Novacta Biosystems Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
4. Bankruptcy: Liquidation 28-Apr-2016 000.00 Completed Bankruptcy: Liquidation
3. Early Stage VC 06-Jul-2009 000.00 000.00 Completed Generating Revenue
2. Grant 14-Jan-2008 $6.93M $826K Completed Generating Revenue
1. Early Stage VC 07-Aug-2007 $826K $826K Completed Generating Revenue
To view Novacta Biosystems’s complete valuation and funding history, request access »

Novacta Biosystems Comparisons

Description
Primary
Industry
HQ Location
Employees
Total Raised
Post Valuation
Last Financing Details
Provider of a clinical stage bio-pharmaceutical services intended to treat bacterial infections. The company's clinical
Drug Discovery
Hertfordshire, United Kingdom
51 As of 2016
000.00
000000000000 000.00

00000000

voluptate velit esse cillum dolore eu fugiat nulla pariatur. Excepteur sint occaecat cupidatat non p
0000 000000000
San Diego, CA
000 As of 0000
00000
0000000 0000 00000

00000 00

at. Duis aute irure dolor in reprehenderit in voluptate velit esse cillum dolore eu fugiat nulla par
0000 000000000
NY
0 As of 0000
00.000
00000000 00.000
Add Comparison

PitchBook’s comparison feature gives you a side-by-side look at key metrics for similar companies. Personalize which data points you want to see and create visualizations instantly.

Request a free trial

Novacta Biosystems Competitors (42)

Company Name Financing Status Location Employees Total Raised Last Financing Date/Type Last Financing Amount
Biosplice Therapeutics Private Equity-Backed San Diego, CA 000 00000 0000000 0000 00000
00000 000000000000 Corporation NY 0 00.000 00000000 00.000
000000 00000 Private Equity-Backed Durham, NC 00 00000 000000000000 00000
0000000 000000 Venture Capital-Backed Barcelona, Spain 00 000.00 000000000000 000.00
000000 00000000000 Formerly VC-backed San Diego, CA 00 00000 000000&0 00000
You’re viewing 5 of 42 competitors. Get the full list »

Novacta Biosystems Executive Team (1)

Name Title Board Seat Contact Info
Michael Dawson Ph.D Chief Scientific Officer & Board Member
To view Novacta Biosystems’s complete executive team members history, request access »

Novacta Biosystems Board Members (8)

Name Representing Role Since
Andrew Richards Ph.D Self Board Member 000 0000
Michael Dawson Ph.D Self Chief Scientific Officer & Board Member 000 0000
Michael Earl Novacta Biosystems Board Member 000 0000
Nigel Brooksby Self Board Member 000 0000
Stephen Parker Self Board Member 000 0000
You’re viewing 5 of 8 board members. Get the full list »

Novacta Biosystems Signals

Growth Rate

0.80% Weekly
Growth
Weekly Growth 0.80%, 93rd %ile
-35.5%. 530%

Size Multiple

219x Median
Size Multiple 219x, 100th %ile
0.00x 0.95x. 413Kx

Key Data Points

Twitter Followers

5.5k

Similarweb Unique Visitors

15.0K

Majestic Referring Domains

314

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial